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The italian registry of conservative renal Surgery (record1 Project) is a mul-
ticenter, observational, prospective project 
developed in 2008 promoted by the leading 
Urological Non-Profit Foundation for Ad-
vanced research (lUNa) of the italian So-
ciety of Urology (SiU) involving 19 italian 
centers. The aim of this project was to offer 
a comprehensive view of the national trend 
of utilization of conservative kidney surgery 
and to offer a “real-life” description of the 
clinical, perioperative, pathological as well as 
oncological and functional results in patients 
treated with NSS for renal tumors in italy from 
2009 to 2012, to provide evidence on a sig-
nificant gap of knowledge, such as: 1) the im-
pact of the surgical approach (oPN vs. lPN 
vs. raPN) on outcomes according to tumors’ 
and patients’ characteristics; 2) the feasibility 
of widening the indications of minimally inva-
sive techniques to larger and more complex tu-
mors; 3) the performance of different surgical 
techniques (enucleation vs. enucleoresection/
standard partial nephrectomy); 4) the trend in 
the use of hemostatic agents and their putative 
protective effect against bleeding and finally; 
5) the impact of several epidemiological and 
clinical factors on postoperative outcomes 
(complications, renal function [rf] and onco-
logic outcome) after NSS. 
This was the first multicenter online web-
based database for kidney surgery in italy and 
it comprises 6 main categories: 1) anthropo-
metric and preoperative data; 2) imaging, in-
dications and comorbidities; 3) intraoperative 
data; 4) postoperative data; 5) histopathologi-
cal analysis; 6) follow-up. all data were cen-
trally recorded on a data server. 
overall, the clinical data of 1055 patients 
were recorded. Patients undergoing NSS were 
found to be increasingly younger, healthier, 
and with larger tumor diameter over the pe-
riod considered. Notably, a constant decrease 
in the use of the oPN both for cT1a and cT1b 
over time was reported. raPN increased in 
the last two years, while lPN seemed a well-
established and adopted procedure in the ital-
ian centers resulting in a slight decrease of its 
utilization over time. enucleoresection was the 
most widely adopted technique (60%) among 
centers with a not negligible use of enucleation 
(40%). The attitude towards an off-clamp pro-
cedure increased over time for all the three ap-
proaches. The WIT did not differ significantly, 
and the median WiT was always <20 minutes.1 
LPN was confirmed to be not inferior to 
oPN in clinical T1a tumors in a matched pair 
analysis of patients within the record1 
project. Indeed, no significant difference in 
achieving the TrifecTa outcome and in re-
nal function decrease at the 6th month from 
surgery was reported after oPN and lPN al-
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nuclear grade were found to be independent 
predictors of PSM.9 imperative indication and 
PSM status were independent predictors of ip-
silateral renal recurrence.10
The surgical modifiable factors (the open 
and laparoscopic vs robotic approach and the 
on-clamp vs off-clamp) were independent pre-
dictors of immediate (3rd postoperative day) 
and early (1st month) functional deterioration 
after PN, conversely other clinical non-modi-
fiable factors (female gender, age and baseline 
renal function) were correlated to immediate 
and early renal function decline but also to late 
(24th month) functional deterioration.11 Un-
controlled diabetes mellitus was independent-
ly correlated to late functional impairment, 
only. The late functional impairment together 
with BMi were showed to be independent pre-
dictors of cardiovascular events at a median 
follow-up of 86 months. 
The excellent results of this study have 
prompted the scientific committee to promote 
a new study on renal surgery (including radical 
and ablative therapies) for renal tumors: the 
record2 project prospectively included over 
4300 patients undergone surgery from 2013 to 
2016 in 34 italian centers. follow-up of these 
patients is ongoing as well as statistical analy-
ses. This project focused on the indication and 
the effectiveness of the currently available 
therapeutic strategies for the treatment of pa-
tients with localized renal tumors. The results 
of record2 project will soon be published. 
While the record2 project is ending (in-
clusion phase closed in December 2016 and 
follow-up recording will close December 
2018), the i-recorD (international) project 
is about to start early 2018. The project will 
reproduce the design of a prospective, obser-
vational, adaptable, clinical trial, recalling the 
concept of multi-arm multistage platform. The 
aim of the study is to define a-priori groups 
of patients selected with renal neoplasia based 
on tumors’ and patients’ characteristics and the 
hospital resources. Designing a subdivision 
into parallel and dynamic study arms might 
provide the base to set research questions of 
current and future interest in the treatment of 
localized/locally advanced renal tumors.
though the latter was associated with a signifi-
cantly longer WiT.2 in another study within the 
record 1 project, patients who underwent 
raPN showed equivalent surgical, early on-
cological and functional outcomes and a sig-
nificantly lower overall postoperative compli-
cation rate compared to oPN.3 This result was 
confirmed also for the treatment of cT1b tu-
mors. The study showed that clinical T1b renal 
tumors could be safely treated by a minimally 
invasive approach (either lPN or raPN) in 
high-volume centres, and that raPN was as-
sociated with a significantly lower WIT and 
blood loss compared with lPN.4, 5
The analysis on the performance of differ-
ent surgical techniques (enucleation vs. enu-
cleoresection/standard partial nephrectomy) 
showed that simple enucleation (Se) is associ-
ated with a significantly lower blood loss and 
shorter operative time, but comparable medi-
cal and surgical complications to standard PN. 
furthermore, standard PN was an independent 
predictor of positive surgical margins (PSM) 
with a 4.7-fold increased risk compared to 
Se.6 another study, evaluating the trend in 
the use of hemostatic agents and their puta-
tive protective effect against bleeding showed 
that hemostatic agents are widely adopted dur-
ing NSS, 83% of the procedures required the 
use of an hemostatic agent, but no differences 
were found in terms of postoperative outcomes 
between TachoSil® (Takeda Pharma), floseal® 
(Takeda, inc.) and their non-use (TriMatch sta-
tistical analysis after balancing for confound-
ing factors) thus suggesting that adding hemo-
static agents to renorrhaphy during NSS does 
not provide better surgical outcomes.7
in the record1 project, prognostic factors 
of postoperative surgical complications, onco-
logical and functional outcomes were also in-
vestigated. The presence of comorbidities and 
the surgical open (compared to robotic) ap-
proach were independent predictors of overall 
and major surgical complications.8 converse-
ly, age, body mass index (BMi), nephrometry 
parameters and surgical indication were not.8
from an oncological perspective, higher 
age, upper pole tumor location, enucleores-
ection versus enucleation, and fuhrman 3-4 
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